Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The proline-rich region of 18.5-kDa myelin basic protein binds to the SH3-domain of Fyn tyrosine kinase with the aid of an upstream segment to form a dynamic complex in vitro.
Cutaneous Adverse Events Associated with Interferon-β Treatment of Multiple Sclerosis.
B lymphocyte proliferation is suppressed by the opioid growth factor-opioid growth factor receptor axis: Implication for the treatment of autoimmune diseases.
Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP).
Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis.
Self-rated health in women prior to clinical onset of multiple sclerosis: A study within the Danish National Birth Cohort.
Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.
Sarcoidosis with neurological involvement imitating multiple sclerosis: The importance of thoracic imaging.
Metaboreflex activity in multiple sclerosis patients.
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
Effects of a Tailored Positive Psychology Intervention on Well-being and Pain in Individuals with Chronic Pain and a Physical Disability: A Feasibility Trial.
Leber's hereditary optic neuropathy masquerading as optic neuritis with spontaneous visual recovery.
Ecotropic Murine Leukemia Virus Infection of Glial Progenitors Interferes with Oligodendrocyte Differentiation: Implications for Neurovirulence.
Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.
Identification of Tmem10 as a Novel Late-stage Oligodendrocytes Marker for Detecting Hypomyelination.
A study of psychological well-being in people with multiple sclerosis and their primary caregivers.
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.
The Lin28/let-7 axis is critical for myelination in the peripheral nervous system.
Upregulation of voltage-gated Ca(2+) channels in mouse astrocytes infected with Theiler's murine encephalomyelitis virus (TMEV).
Optic neuritis revealing Kikuchi-Fujimoto's disease: clinical commentary.
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.
New data show Novartis' Gilenya® reduced brain volume loss by one third and confirm brain volume loss link with disability in MS patients
A systematic review of drugs in late-stage development for the treatment of multiple sclerosis: a focus on oral synthetic drugs.
Caregiver burden in multiple sclerosis: A structured review of the instruments.
Pages
« first
‹ previous
…
559
560
561
562
563
564
565
566
567
…
next ›
last »